MME could catalyze the activity of the PENT tumor suppressor protein and could inhibit the phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) signaling pathway to reduce cell survival and migration in cancer growth [54]. The gene discussed is AKT1; the disease is cancer.